Rajesh Salve

542 total citations · 1 hit paper
15 papers, 369 citations indexed

About

Rajesh Salve is a scholar working on Molecular Biology, Biomaterials and Polymers and Plastics. According to data from OpenAlex, Rajesh Salve has authored 15 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Biomaterials and 4 papers in Polymers and Plastics. Recurrent topics in Rajesh Salve's work include Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (10 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Rajesh Salve is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (10 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Rajesh Salve collaborates with scholars based in India, Saudi Arabia and United States. Rajesh Salve's co-authors include Virendra Gajbhiye, Afsana Sheikh, Prashant Kesharwani, Kavita R. Gajbhiye, Pramod Kumar, Mohammed A. S. Abourehab, Worapol Ngamcherdtrakul, Wassana Yantasee, Kishore M. Paknikar and Bhushan P. Chaudhari and has published in prestigious journals such as International Journal of Pharmaceutics, Molecular Cancer and Journal of Pharmaceutical Sciences.

In The Last Decade

Rajesh Salve

15 papers receiving 362 citations

Hit Papers

Lipid polymer hybrid nanoparticles: a custom-tailored nex... 2023 2026 2024 2025 2023 40 80 120

Peers

Rajesh Salve
Mona Kalmouni United Arab Emirates
Iulian Bobe United States
Rajesh Salve
Citations per year, relative to Rajesh Salve Rajesh Salve (= 1×) peers Linlin Shi

Countries citing papers authored by Rajesh Salve

Since Specialization
Citations

This map shows the geographic impact of Rajesh Salve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajesh Salve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajesh Salve more than expected).

Fields of papers citing papers by Rajesh Salve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajesh Salve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajesh Salve. The network helps show where Rajesh Salve may publish in the future.

Co-authorship network of co-authors of Rajesh Salve

This figure shows the co-authorship network connecting the top 25 collaborators of Rajesh Salve. A scholar is included among the top collaborators of Rajesh Salve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajesh Salve. Rajesh Salve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Salve, Rajesh, et al.. (2024). MUC1 aptamer-tethered H40-TEPA-PEG nanoconjugates for targeted siRNA-delivery and gene silencing in breast cancer cells. Frontiers in Bioengineering and Biotechnology. 12. 1383495–1383495. 4 indexed citations
2.
Salve, Rajesh, et al.. (2024). αvβ3 integrin-targeted pH-responsive dendritic nanocarriers for enhanced anti-tumor efficacy of docetaxel against breast cancer. Journal of Drug Delivery Science and Technology. 99. 105946–105946. 4 indexed citations
3.
Sheikh, Afsana, Shadab Md, Rajesh Salve, et al.. (2023). GLUT1 transporter-facilitated solid lipid nanoparticles loaded with anti-cancer therapeutics for ovarian cancer targeting. International Journal of Pharmaceutics. 637. 122894–122894. 27 indexed citations
4.
Salve, Rajesh, Pramod Kumar, Bhushan P. Chaudhari, & Virendra Gajbhiye. (2023). Aptamer Tethered Bio-Responsive Mesoporous Silica Nanoparticles for Efficient Targeted Delivery of Paclitaxel to Treat Ovarian Cancer Cells. Journal of Pharmaceutical Sciences. 112(5). 1450–1459. 13 indexed citations
5.
Tambe, Prajakta, Rajesh Salve, Prakash Choudhary, et al.. (2023). Targeted silencing of the MCL-1 gene using multi-layered dendrimer-based nanoconstructs achieves efficient tumor regression in xenografted mice models. International Journal of Pharmaceutics. 634. 122659–122659. 9 indexed citations
6.
Gajbhiye, Kavita R., et al.. (2023). Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics. Molecular Cancer. 22(1). 160–160. 129 indexed citations breakdown →
7.
Kesharwani, Prashant, Afsana Sheikh, Mohammed A. S. Abourehab, Rajesh Salve, & Virendra Gajbhiye. (2023). A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy. Journal of Drug Delivery Science and Technology. 80. 104164–104164. 49 indexed citations
8.
Salve, Rajesh, et al.. (2022). Challenges and emerging strategies for next generation liposomal based drug delivery: An account of the breast cancer conundrum. Chemistry and Physics of Lipids. 250. 105258–105258. 6 indexed citations
9.
Kumar, Pramod, Rajesh Salve, Kishore M. Paknikar, & Virendra Gajbhiye. (2022). Nucleolin aptamer conjugated MSNPs-PLR-PEG multifunctional nanoconstructs for targeted co-delivery of anticancer drug and siRNA to counter drug resistance in TNBC. International Journal of Biological Macromolecules. 229. 600–614. 28 indexed citations
10.
Tiwari, Ankita, Virendra Gajbhiye, Ankit Jain, et al.. (2022). Hyaluronic acid functionalized liposomes embedded in biodegradable beads for duo drugs delivery to oxaliplatin-resistant colon cancer. Journal of Drug Delivery Science and Technology. 77. 103891–103891. 13 indexed citations
11.
Jadon, Rajesh S., Gajanand Sharma, Neeraj Garg, et al.. (2021). Efficient in vitro and in vivo docetaxel delivery mediated by pH-sensitive LPHNPs for effective breast cancer therapy. Colloids and Surfaces B Biointerfaces. 203. 111760–111760. 15 indexed citations
12.
Salve, Rajesh, Pramod Kumar, Worapol Ngamcherdtrakul, Virendra Gajbhiye, & Wassana Yantasee. (2021). Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery. Materials Science and Engineering C. 124. 112084–112084. 43 indexed citations
13.
Bera, Hriday, et al.. (2021). Chemosensitivity assessments of curdlan-doped smart nanocomposites containing erlotinib HCl. International Journal of Biological Macromolecules. 181. 169–179. 7 indexed citations
14.
Meshram, Rohan J., et al.. (2021). Novel 3-fluoro-4-morpholinoaniline derivatives: Synthesis and assessment of anti-cancer activity in breast cancer cells. Journal of Molecular Structure. 1253. 132127–132127. 3 indexed citations
15.
Salve, Rajesh, et al.. (2020). Biodegradable dendritic Boltorn™ nanoconstructs: A promising avenue for cancer theranostics. International Journal of Pharmaceutics. 594. 120177–120177. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026